Trade AstraZeneca ^AZN

Erste Group Bank Expects Increased Earnings for Astrazeneca

Astrazeneca (NYSE:AZN) Rating Lowered to Hold at Wall Street Zen - Markets Daily

Greener Pharma Manufacturing Faces the Scale-Up Test

Amid the Biotech Madness, I Spotted an Opening in a Promising Small-Cap

AstraZeneca HPP Drug Shows Gains Despite Missing Key Phase III Endpoint - Stock Observer

Astrazeneca Plc (AZN) - What Are Researchers Saying About This Stock?

AstraZeneca announces ALXN1850 did not achieve statistical significance

NSCLC Pipeline 2026: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | AbbVie, Xcovery, Sanofi, Pfizer, Mirati Therapeutics, AstraZeneca, Daiichi Sankyo, Merck | ABNewswire

Astrazeneca (NYSE:AZN) Downgraded by Wall Street Zen to "Hold"

AZN: Patent Fears Still Matter, New Growth Now Rests On Late Stage Depth

3 British AI Healthcare Stocks With Revenue Growth Up To 14%

Biopharma giant opens $1B Cambridge research hub for nearly 2K scientists, researchers

Death threats by fired AstraZeneca scientist brings jail time - WHYY

AstraZeneca (LON:AZN) Hits New 52-Week Low - What's Next? - Zolmax

AstraZeneca's (AZN) Buy Rating Reiterated at Berenberg Bank

AstraZeneca (LON:AZN) Earns "Buy" Rating from Berenberg Bank - Zolmax

AstraZeneca's (AZN) Buy Rating Reaffirmed at Berenberg Bank - Zolmax

SOPHiA GENETICS (NASDAQ:SOPH) Stock: Insider Zhenyu Xu Sells 7,394 Shares - Daily Political

Sun Pharmaceutical Industries Ltd Option Chain & Strike Prices | IIFL Capital

Sun Pharmaceutical Industries Ltd Futures Share Price & Chart Today | IIFL Capital

Proteome-guided drug discovery maps and mitigates therapeutic degrader toxicity

Astrazeneca Plc $AZN Stock Bought by Professional Advisory Services Inc. - Zolmax

AstraZeneca (LON:AZN) Given Buy Rating at Jefferies Financial Group - Daily Political

AstraZeneca (LON:AZN) Earns "Buy" Rating from Jefferies Financial Group - Daily Political

AstraZeneca (AZN) Seeks FDA Approval for New Lung Cancer Treatment. Can It Fuel Oncology Growth?

Astrazeneca Plc $AZN Holdings Boosted by Professional Advisory Services Inc. - Daily Political

Myriad Genetics, SOPHiA GENETICS Partner With AstraZeneca On Prostate Cancer PrGIS

Astrazeneca Plc $AZN Stock Acquired by Gradient Investments LLC - Stock Observer

SOPHiA GENETICS Partners Myriad Genetics To Advance Prostate Genomic Instability Score Technology

SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology

AstraZeneca (LON:AZN) Stock Keeps "Buy" Rating at Berenberg Bank

Chemotherapy Group Stuns with Exceptional Performance, Delivering a Crushing Blow to Allist's Global Ambitions

Analyzing Astrazeneca (NYSE:AZN) and Biofrontera (NASDAQ:BFRI) - Daily Political

Head-To-Head Analysis: Vanda Pharmaceuticals (NASDAQ:VNDA) vs. Astrazeneca (NYSE:AZN) - Zolmax

Financial Analysis: Vanda Pharmaceuticals (NASDAQ:VNDA) & Astrazeneca (NYSE:AZN) - Markets Daily

Combined limbal dysmaturation and microcyst like epithelial changes with corneal nerve alterations of a novel anti nectin-4-MMAE antibody drug conjugate

Canandaigua National Bank & Trust Co. Purchases 11,271 Shares of Astrazeneca Plc $AZN

Astrazeneca Plc $AZN Shares Newly Acquired by Canandaigua National Bank & Trust Co. - Stock Observer

AstraZeneca (LSE:AZN) Stock Looks Reasonable Based On Current Earnings

Deals/M&As: Gate's $870M Lilly deal expansion; Spyglass buys AVS

Summit Therapeutics Stock Has The Bull Case Changed After AstraZeneca Backing

Startup Funding News Today, October 7, 2026: Nous Research, Monid, Multiply Labs, Quanfluence & More

Jefferies Financial Group Reaffirms Buy Rating for AstraZeneca (LON:AZN)

AstraZeneca's Etcamah: A Game-Changer in Breast Cancer Treatment Approved in India, ETPharma

How Investors Are Reacting To Daiichi Sankyo Company (TSE:4568) Expanding Datroway's Oncology Combination Program

AstraZeneca (LON:AZN) Stock Rating Reaffirmed as "Buy" by Berenberg Bank

AstraZeneca PLC (LON:AZN) Stock Has Consensus Price Target of £150 - Markets Daily

AstraZeneca CEO Pascal Soriot on Summit ivonescimab combos

Best Manufacturing Stocks To Watch Today - October 6th - Daily Political

Is this under-the-radar FTSE 250 biotech gem set to soar from £5.43 to £13.92?

Philippines vies for Asia clinical research hub | Daily Tribune

AstraZeneca CEO Pascal Soriot on new Boston site: Faster, better development of new products is the hope

AstraZeneca opens $1 billion R&D center in Massachusetts

Park National Corp OH Purchases 67,214 Shares of Astrazeneca Plc $AZN

AstraZeneca opens new global strategic R&D center in Kendall Square, Cambridge, Massachusetts | Morningstar

Clinical trial experts turn to AI and new partnerships to tackle growing trial complexity

Barclays Sticks to Their Buy Rating for AstraZeneca (AZN)

Meet the UK growth stock that's forecast to climb 35% - and whose boss just bought £7.3m of its shares

DTI, AstraZeneca deepen Philippines clinical | Daily Tribune

COPD trial wins spur broad respiratory hopes

AstraZeneca PLC (LON:AZN) Stock Rated "Moderate Buy" by Sell-Side Brokerages

Astrazeneca (NYSE:AZN) & Redhill Biopharma (NASDAQ:RDHL) Financial Analysis

Summit Therapeutics (SMMT) Is Up 7.3% After $2 Billion AstraZeneca Partnership and Trial Collaboration

AstraZeneca and Daiichi Sankyo Join Summit Therapeutics to Advance Cancer Treatment, ETPharma

Weekly Buzz: EW, ABBV, MIRM Score FDA Wins, AZN, NVO Strike Deals; LLY, KOD Report Data

Summit Therapeutics (SMMT), What Is Behind The Fresh Attention?

Daiichi Sankyo, AstraZeneca, Summit Partner On Datroway- Ivonescimab Cancer Studies

Summit Therapeutics Announces Clinical Trial Collaboration with AstraZeneca and Daiichi Sankyo to Evaluate Ivonescimab in Combination with TROP2-Directed ADC Datroway | Morningstar

Daiichi Sankyo and AstraZeneca Enter into Clinical Trial Collaboration with Summit Therapeutics to Evaluate Datroway® in Combination with Ivonescimab Across Multiple Tumor Types | Morningstar

AstraZeneca (LON:AZN) Stock Keeps Hold Rating at Deutsche Bank Aktiengesellschaft - Markets Daily

AstraZeneca's (AZN) Hold Rating Reiterated at Deutsche Bank Aktiengesellschaft - Markets Daily

Deutsche Bank Aktiengesellschaft Reaffirms "Hold" Rating for AstraZeneca (LON:AZN) - Markets Daily

AstraZeneca (AZN) Puts $2 Billion Into Summit Therapeutics (SMMT) for a Cancer Tie-Up

Association of hypertension specialist treatment with blood pressure control in Japanese primary care: The J-DOME study

Urine cell-free RNA for bladder cancer detection and treatment response prediction

AstraZeneca Stocks Drops as $2 Billion Buys an Oncology Option

What Does Summit Therapeutics (SMMT) Gain From This $2 Billion Cancer Partnership?

Effects of semaglutide on kidney disease in type 2 diabetes: a randomized placebo-controlled trial

700,000 Seniors Have Started GLP-1s Through Medicare. Now AstraZeneca Just Moved a Once-Daily Pill Into Phase 3

AstraZeneca's $2 Billion Vote of Confidence Leaves Summit Therapeutics Trading Well Below Street Targets

AstraZeneca Dealt Latest Loss in Arkansas Drug Discount Case

Drug Repurposing Market - Global Strategic Business Report: Forecasts Growth to $37.3Billion by 2030, Profiling AbbVie, AstraZeneca, Pfizer, Novartis & Johnson & Johnson

Is AstraZeneca (LSE:AZN) Undervalued Following Its New Lung Cancer FDA Filing?

Contrasting Tarsus Pharmaceuticals (NASDAQ:TARS) & Astrazeneca (NYSE:AZN)

Head-To-Head Contrast: Astrazeneca (NYSE:AZN) vs. Tarsus Pharmaceuticals (NASDAQ:TARS) - Stock Observer

Safety and efficacy of ceralasertib, an ATR kinase inhibitor, combined with olaparib: dose escalation in advanced solid tumours and dose expansion in advanced breast cancer

Periarterial nerves along the human hepatic artery: anatomical determinants for cardiometabolic neuromodulation

A $2 Billion Reason Why AstraZeneca Stock Is Down Today

Biotech Stocks On The Move - SLXN, SMMT, IOVA, NTHI

Summit Stock Jumps 17% on $2 Billion AstraZeneca Investment

Summit Therapeutics Stock Rises 7% After AstraZeneca Strategic Investment

AstraZeneca's (AZN) Hold Rating Reaffirmed at Deutsche Bank Aktiengesellschaft

Why is Summit Therapeutics share price up today by 22%?

Biotech Pre-Market Movers: SLXN, SMMT Surge; NIVF, QURE Slide

AstraZeneca Invests $2B in Summit for Cancer Drug Dev

Are Memory Stocks Still a Buy After the Selloff?

Best Stock CFD Broker in 2026: 9 Platforms Compared

Gold Price Forecast Today and Next 30 Days: Can XAU/USD Extend Its Weekly Rebound?

ASML Stock Forecast 2026–2030: Can It Reach a $1 Trillion Valuation?

GE Vernova Stock Forecast & Analysis: Will Data-Centre Power and Grid Investment Fuel the Next Rally?

Samsung Electronics Stock Price Forecast 2026–2027: Can Record Q3 Profit Extend the AI Rally?

Is SpaceX a Good Stock to Buy in 2026?

Best Gold Stock to Buy Now: 6 Gold Stocks to Watch in 2026

Advanced CFD Trading Tools Review: Which Tools Can Improve Your Trading Decisions?

Gold Price Trend 2024-2026: From $2,000 to Record Highs, What Comes Next?

Silver Price Today: XAG/USD Holds Near $59.15 Ahead of US CPI

Gold Price Today: XAU/USD Trades Near $4,153 Ahead of US CPI

Character.AI Files for Bankruptcy as Disney Bids $20 Million for Its Assets

Apple Stock Hits Record High on HomeView Launch Before Gains Fade

Applied Materials Stock Falls 6.7% as Memory Chip Selloff Hits Global Markets

Goldman Sachs Earnings Crush Forecasts, but GS Stock Reverses as Bond Trading Slows

Solana Prepares for Alpenglow Upgrade as SOL Eyes a Return to $125

Citigroup Stock Sinks 5.6% Despite a 40% Profit Jump and Decade-High Q3 Revenue